Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Insider trading.

<< Previous

Bullboard Posts

Next >>

Comment by okgonowon Apr 02, 2024 9:06am

77 Views

Post# 35964674

RE:RE:Insider trading.

QContinuum1 wrote: Have they traded on the open market? If not, they did nothing illegal and inferring that without proof could be seen as libelous.

PROOF

Date	Issuer	Insider	Transaction	Amount	New Balance
Filed 2023-08-23 09:23 Tx date 2023-08-18	$LABS MediPharm Labs Corp.	Strachan, Keith 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-10,463.175 -139,509 vol $0.075 each	1,753,663
Filed 2023-06-30 19:16 Tx date 2023-06-22	$LABS MediPharm Labs Corp.	Strachan, Keith 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-15,615.84 -260,264 vol $0.06 each	1,656,393
Filed 2023-06-27 13:03 Tx date 2023-06-22	$LABS MediPharm Labs Corp.	Hunter, Gregory Edison 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-12,675.42 -211,257 vol $0.06 each	537,417
Filed 2023-05-24 16:34 Tx date 2023-05-19	$LABS MediPharm Labs Corp.	Pidduck, David 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-142,181.34 -2,031,162 vol $0.07 each	6,175,735
Filed 2022-01-11 18:51 Tx date 2021-09-15	$LABS MediPharm Labs Corp.	Hunter, Gregory Edison 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-9,331.7361 -29,919 vol $0.3119 each	34,061
Filed 2022-01-11 18:51 Tx date 2021-05-19	$LABS MediPharm Labs Corp.	Hunter, Gregory Edison 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-12,124.144 -30,040 vol $0.4036 each	16,970
Filed 2021-11-26 12:04 Tx date 2021-11-26	$LABS MediPharm Labs Corp.	Howcroft, Bryan 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$22,500 +100,000 vol $0.225 each	100,000
Filed 2021-11-23 10:00 Tx date 2021-11-19	$LABS MediPharm Labs Corp.	McCutcheon, Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-345.00 -1,500 vol $0.23 each	7,565,240
Filed 2021-11-23 09:59 Tx date 2021-11-18	$LABS MediPharm Labs Corp.	McCutcheon, Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-76,727.50 -326,500 vol $0.235 each	7,566,740
Filed 2021-11-23 09:58 Tx date 2021-11-17	$LABS MediPharm Labs Corp.	McCutcheon, Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-42,140 -172,000 vol $0.245 each	7,893,240
Filed 2021-11-22 14:20 Tx date 2021-09-15	$LABS MediPharm Labs Corp.	Everitt, Warren 4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$13,890 +44,536 vol $0.3119 each
Filed 2021-11-22 13:47 Tx date 2021-11-19	$LABS MediPharm Labs Corp.	Everitt, Warren 4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-86,520.4818 -359,603 vol $0.2406 each	2,026,950